Hancock Whitney’s NeoGenomics NEO Stock Holding History

Hancock Whitney’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,405	Closed	-$88K	–	563
2015 Q3	$88K	Buy	+15,405	New	+$95.4K	﹤0.01%	505

Other funds holding NEO

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Artisan Partners

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Hancock Whitney's NEO Position: Q4 2015 in Review

Hancock Whitney sold out of NeoGenomics (NEO) in Q4 2015, closing a stake of 15,405 shares — an estimated $88K sold.

Hancock Whitney first reported a position in NEO in Q3 2015 and held it in 1 quarter. The position peaked at $88K in Q3 2015. 119 funds tracked by Wall St. Rank hold NEO as of Q4 2015.

Hancock Whitney reported no remaining NeoGenomics position as of Q4 2015 after selling out during the quarter.
Hancock Whitney sold 15,405 NeoGenomics shares in Q4 2015, an estimated $88K.
Hancock Whitney first reported a position in NeoGenomics in Q3 2015 and held it in 1 quarter.
Hancock Whitney's NeoGenomics position peaked at $88K in Q3 2015.
119 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2015.

Based on Hancock Whitney's 13F filing for Q4 2015, filed 12 Feb 2016.